Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension: a Multicentre Prospective Randomized Study

NCT07470580 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT07470580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07470580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation Versus Adrenalectomy for Adenoma in Patients With Primary Aldosteronism and Hypertension: a Multicentre Prospective Randomized Study
Lead sponsor
University Hospital, Toulouse
Phase
Not applicable
Overall status
Recruiting
Start date
June 5, 2026
Completion date
June 1, 2030
Enrollment
134 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenalectomy, primary aldosteronism due to conn adenoma, radiofrequency ablation treatment